Skip to main content
SpringerLink
Log in

Type of arteriovenous fistula, NYHA class and apelin in hemodialyzed patients

  • Nephrology - Original Paper
  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

Apelin, a newly discovered adipocytokine, is produced by white adipose tissue and also expressed in kidney and heart. Increasing evidence suggests a role for apelin in the pathology of the cardiovascular system. It was demonstrated that apelin may contribute to the pathophysiology of human chronic heart failure. Apelin locates at the endothelium—a site of key functional importance in the kidney, and apelin has been shown to increase cardiac output. Cardiovascular disease is a major contributor to the mortality and morbidity of patients with chronic renal failure. We previously found that apelin was significantly lower in dialyzed patients with coronary artery disease and its level was predicted by cardiac function. Creation of a-v fistula might contribute to the development or worsening of chronic heart failure. The aim of this study was to assess associations between apelin, other adipocytokines, NYHA class and location of a-v fistula in hemodialyzed patients. This cross-sectional study was performed on a cohort of one hundred, clinically stable hemodialyzed patients. We investigated plasma apelin as well other adipocytokines: resistin, visfatin and von Willebrand factor (vWF)—a marker of endothelial cell injury. In patients with a-v fistula on the forearm (n = 77), apelin was significantly higher than in patients with a-v fistula on the arm (n = 23) (56.79 ± 23.56 vs. 43.12 ± 23.19 pg/ml). Patients with forearm a-v fistula had lower left ventricular internal end-diastolic dimension (LVIDd) (P < 0.05), left ventricular internal end-systolic dimension (LVISd) (P < 0.05), NYHA class (P < 0.05), hsCRP (P < 0.01), plasma vWF (P < 0.01), and plasma resistin (P < 0.05), whereas the ejection fraction was higher than in patients with arm a-v fistula (P < 0.05), as well as hemoglobin (P < 0.05), hematocrit (P < 0.01), prevalence of diabetes (n < 0.05), prevalence of coronary heart disease (P < 0.05), serum pH (P < 0.05), serum bicarbonate (P < 0.05). Apelin was related to echocardiographic parameters, presence of diabetes, coronary artery disease, chronic heart failure, NYHA class and serum lipids (total cholesterol, LDL, triglycerides), hsCRP, vWF, residual renal function, and Kt/V. In multiple logistic regression analysis, apelin was significantly associated with ejection fraction (beta value was −0.51, P = 0.007), the presence of diabetes (beta value 0.39, P = 0.049), a-v fistula arm location (beta value 0.42, P = 0.047). Multiple adjusted r 2 for variables in the equation = 0.45, F = 1.75, P = 0.04, SE of estimate = 20.85. Apelin level in dialyzed patients is predicted by cardiac function, presence of diabetes and location of a-v fistula. Apelin might be involved in the pathophysiology of cardiovascular disease in chronic renal failure. The arm location of the fistula might contribute to the development or the worsening of chronic heart failure in hemodialyzed patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Zhang Y, Proenca R, Maffei M, Barone M, Friedman JM (1994) Positional cloning of the mouse obese and its human homologue. Nature 372:425–432

    Article  PubMed  CAS  Google Scholar 

  2. Guzik TJ, Mangalat D, Korbut R (2006) Adipocytokines–novel link between inflammation and vascular function? J Physiol Pharmacol 57:505–528

    PubMed  CAS  Google Scholar 

  3. Boucher J, Masri B, Daviaud D, Gesta S, Guigne C, Mazzucotelli A, Castan-Laurell I, Tack I, Knibiehler B, Carpene C, Audigier Y, Saulnier-Blache JS, Valet P (2005) Apelin, a newly identified adipokine up-regulated by insulin and obesity. Endocrinology 146:1764–1771

    Article  PubMed  CAS  Google Scholar 

  4. Kleinz MJ, Davenport AP (2005) Emerging roles of apelin in biology and medicine. Pharmacol Ther 107:198–211

    Article  PubMed  CAS  Google Scholar 

  5. Falcao-Pires I, Leite-Moreira AF (2005) Apelin: a novel neurohumoral modulator of the cardiovascular system. Pathophysiologic importance and potential use as a therapeutic target. Rev Port Cardiol 24:1263–1276

    PubMed  Google Scholar 

  6. Charles CJ (2007) Putative role for apelin in pressure/volume homeostasis and cardiovascular disease. Cardiovasc Hematol Agents Med Chem 5:1–10

    PubMed  CAS  Google Scholar 

  7. Sarnak MJ, Levey AS (2000) Cardiovascular disease and chronic renal disease. A new paradigm. Am J Kidney Dis 35(suppl.1):117–131

    Article  Google Scholar 

  8. Malyszko J, Malyszko JS, Kozminski P, Mysliwiec M (2006) Apelin, a novel adipocytokine, and cardiac function in hemodialyzed patients: possible relations? Am J Nephrol 26:121–126

    Article  PubMed  CAS  Google Scholar 

  9. Iwashima Y, Horio T, Takami Y, Inenaga T, Nishikimi T, Takishita S, Kawano Y (2002) Effects of the creation of arteriovenous fistula for hemodialysis on cardiac function and natriuretic peptide levels in CRF. Am J Kidney Dis 40:974–982

    Article  PubMed  CAS  Google Scholar 

  10. Sarnak MJ, Levey AS (1999) Epidemiology of cardiac disease in dialysis patients. Semin Dial 12:69–75

    Article  Google Scholar 

  11. Basile C, Lomonte C, Vernaglione L, Casucci F, Antonelli M, Losurdo N (2008) The relationship between the flow of arteriovenous fistula and cardiac output in haemodialysis patients. Nephrol Dial Transplant 23:282–287

    Article  PubMed  Google Scholar 

  12. Wijnen E, Keuter XH, Planken NR, van der Sande FM, Tordoir JH, Leunissen KM, Kooman JP (2005) The relation between vascular access flow and different types of vascular access with systemic hemodynamics in hemodialysis patients. Artif Organs 29:960–964

    Article  PubMed  Google Scholar 

  13. Foldes G, Horkay F, Szokodi I, Vuolteenaho O, Ilves M, Lindstedt KA, Mayranpaa M, Sarman B, Seres L, Skoumal R, Lako-Futo Z, deChatel R, Ruskoaho H, Toth M (2003) Circulating and cardiac levels of apelin, the novel ligand of the orphan receptor APJ, in patients with heart failure. Biochem Biophys Res Commun 308:480–485

    Article  PubMed  CAS  Google Scholar 

  14. Szokodi I, Tavi P, Foldes G, Voutilainen-Myllyla S, Ilves M, Tokola H, Pikkarainen S, Piuhola J, Rysa J, Toth M, Ruskoaho H (2002) Apelin, the novel endogenous ligand of the orphan receptor APJ, regulates cardiac contractility. Circ Res 91:434–440

    Article  PubMed  CAS  Google Scholar 

  15. Atluri P, Morine KJ, Liao GP, Panlilio CM, Berry MF, Hsu VM, Hiesinger W, Cohen JE, Joseph Woo Y (2007) Ischemic heart failure enhances endogenous myocardial apelin and APJ receptor expression. Cell Mol Biol Lett 12:127–138

    Article  PubMed  CAS  Google Scholar 

  16. Kasai A, Shintani N, Oda M, Kakuda M, Hashimoto H, Matsuda T, Hinuma S, Baba A (2004) Apelin is a novel angiogenic factor in retinal endothelial cells. Biochem Biophys Res Commun 325:395–400

    Article  PubMed  CAS  Google Scholar 

  17. Kocher AA, Schuster MD, Szabolcs MJ, Takuma S, Burkhoff D, Wang J, Homma S, Edwards NM, Itescu S (2001) Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 7:430–436

    Article  PubMed  CAS  Google Scholar 

  18. Kawamata Y, Habata Y, Fukusumi S, Hosoya M, Fujii R, Hinuma S, Nishizawa N, Kitada C, Onda H, Nishimura O, Fujino M (2001) Molecular properties of apelin: tissue distribution and receptor binding. Biochim Biophys Acta 1538:162–171

    Article  PubMed  CAS  Google Scholar 

  19. Sheikh AY, Chun HJ, Glassford AJ, Kundu RK, Kutschka I, Ardigo D, Hendry SL, Wagner RA, Chen MM, Ali ZA, Yue P, Huynh DT, Connolly AJ, Pelletier MP, Tsao PS, Robbins RC, Quertermous T (2008) In vivo genetic profiling and cellular localization of apelin reveals a hypoxia-sensitive, endothelial-centered pathway activated in ischemic heart failure. Am J Physiol Heart Circ Physiol. 294:H88–H98

    Article  PubMed  CAS  Google Scholar 

  20. Codognotto M, Piccoli A, Zaninotto M, Mion M, Vertolli U, Tona F, Boffa GM (2007) Evidence for decreased circulating apelin beyond heart involvement in uremic cardiomyopathy. Am J Nephrol 27:1–6

    Article  PubMed  CAS  Google Scholar 

  21. Principe A, Melgar-Lesmes P, Fernández-Varo G, del Arbol LR, Ros J, Morales-Ruiz M, Bernardi M, Arroyo V, Jiménez W (2008) The hepatic apelin system: a new therapeutic target for liver disease. Hepatology 48:1193–1201

    Article  PubMed  CAS  Google Scholar 

  22. Daviaud D, Boucher J, Gesta S, Dray C, Guigne C, Quilliot D, Ayav A, Ziegler O, Carpene C, Saulnier-Blache JS, Valet P, Castan-Laurell I (2006) TNFalpha up-regulates apelin expression in human and mouse adipose tissue. FASEB J 20:1528–1530

    Article  PubMed  CAS  Google Scholar 

  23. Dixon BS (2007) Why don’t fistulas mature? Kidney Int 71:1413–1422

    Article  Google Scholar 

  24. Kats M, Hawxby AM, Barker J, Allon M (2007) Impact of obesity on arteriovenous fistula outcomes in dialysis patients. Kidney Int 71:39–43

    Article  PubMed  CAS  Google Scholar 

  25. Ekmekci H, Ekmekci OB (2006) The role of adiponectin in atherosclerosis and thrombosis. Clin Appl Thromb Hemost 12(2):163–168

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Nephrology and Transplantology, Medical University, 14 Zurawia, Bialystok, 15-540, Poland

    Jolanta Malyszko, Jacek Malyszko & Michal Mysliwiec

  2. Dialysis Unit, Medical University, Dzialdowo, Poland

    Piotr Kozminski

Authors
  1. Jolanta Malyszko
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Piotr Kozminski
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jacek Malyszko
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Michal Mysliwiec
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jolanta Malyszko.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Malyszko, J., Kozminski, P., Malyszko, J. et al. Type of arteriovenous fistula, NYHA class and apelin in hemodialyzed patients. Int Urol Nephrol 43, 185–190 (2011). https://doi.org/10.1007/s11255-009-9667-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11255-009-9667-1

Keywords

Search

Navigation